RemeGen Co., Ltd.
RemeGen Co., Ltd. (HKSE: 9995) is trading at HK$77.10, about ₹943 at today's HKD/INR rate, as of 30 Sep 2026, 4:08 AM ET, up 3.07% today. Indian residents can buy RemeGen from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$73.50
Today's high
HK$77.50
52 week low
HK$63.30
52 week high
HK$126.60
9995 opened at HK$73.50, closed previously at HK$74.80, and has traded between HK$63.30 and HK$126.60 over the past 52 weeks.
About
RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease, rheumatoid arthritis, and myasthenia gravis; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of gastric cancer, urothelial carcinoma, breast cancer, and other tumors. It also develops products in various stages, including RC-28E, a fusion protein that targets vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF); RC88, an antibody-drug conjugate (ADC) that targets mesothelin; and RC148, a bispecific antibody ADC drug that in Phase1/2 clinical studies targeting program cell death protein 1 (PD-1) and VEGF; RC278, an ADC drug for the treatment of multiple solid tumors; and RC288, a dual-antibody ADC drug for the treatment of various tumors. The company was founded in 2008 and is headquartered in Yantai, the People’s Republic of China.
Key statistics
Avg. volume
4.23M
Market cap
HK$42.67B
P/E Ratio
11.29
Price-to-sales ratio
8.11
Enterprise value
CN¥36.53B
Free cash flow yield
-0.39%
Debt-to-equity ratio
0.04
Return on equity
19.66%
ROIC
2.64%
Beta
0.45
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
CN¥3.24B
Earnings per share
CN¥1.29
Free cash flow
-CN¥140.08M
Net profit margin
72.70%
Gross margin
92.67%
EBITDA
CN¥431.72M
Revenue growth
88.81%
Similar securities
This is not an investment recommendation
How to buy RemeGen from India
Indian residents can buy RemeGen shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for RemeGen and place an order
Find RemeGen by name or by its ticker, 9995, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. RemeGen trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your RemeGen position in HKD and INR. RemeGen pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in RemeGen from India
Trading and taxes when buying RemeGen from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneRemeGen does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy RemeGen stock?
Yes. RemeGen (9995) has been listed on the Hong Kong Stock Exchange since 2020, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one RemeGen share cost in rupees?
One RemeGen share is HK$77.10 — about ₹943 at an HKD/INR rate of 12.24 on 29 Sep 2026. Both the RemeGen price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying RemeGen from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of RemeGen?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on RemeGen shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the RemeGen price. Paasa issues a capital-gains statement for your return.
Does RemeGen pay a dividend?
No. RemeGen does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade RemeGen from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is RemeGen a Hong Kong SAR China company, and does that change how it is taxed?
RemeGen trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. RemeGen trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare RemeGen shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your RemeGen holding, its cost and its closing value.
How do I sell RemeGen and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.